AstraZeneca is to sell European rights to its cholesterol drug Crestor (rosuvastatin) to Germany’s Grunenthal. Crestor is a statin and at its peak generated annual revenues of more than $7 ...

Facing US generic competition to its cholesterol drug Crestor next week, AstraZeneca is cutting costs and pinning its hopes on a wave of new cancer drugs. In a Q1 results statement AstraZeneca ...

Crestor (rosuvastatin) and Lipitor (atorvastatin) are the top medications for lowering blood levels of cholesterol and triglycerides. High cholesterol (and triglycerides) occurs when the fat in ...